Diseases, Conditions, Syndromes

New receptor 'decoy' drug neutralizes COVID-19 virus and its variants

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug ...

Diseases, Conditions, Syndromes

A deep dive into the omicron variant's origin

First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed "omicron" spread across the globe at incredible speed. It is still unclear exactly how, when and where this virus originated. Now, a study published ...

Diseases, Conditions, Syndromes

New omicron subvariant largely evades neutralizing antibodies

A study at Karolinska Institutet shows that the coronavirus variant BA.2.75.2, an omicron sublineage, largely evades neutralizing antibodies in the blood and is resistant to several monoclonal antibody antiviral treatments. ...

page 2 from 40